INTRODUCTION
B cells have been mainly described for their capacity to produce antibodies, promote naïve T cell differentiation into helper T cells, and antigen presentation (1) . However, recent data has shown that some B cell subsets play a protective role in various inflammatory animal models such as contact hypersensitivity, experimental autoimmune encephalomyelitis (EAE), collagen-induced arthritis (CIA), inflammatory bowel disease (IBD), and lupus, through the production of IL-10 (2-7). (2) . IL-10-producing T2-MZP and MZ B cells were induced by the stimulation of CD40 signaling pathways to produce IL-10 in a collagen-induced arthritis model (3, 4) . Tedder and coworkers also showed that CD1d hi CD5
+ B cells regulate contact hypersensitivity responses in mice (5). TIM-1 was also suggested as a unique marker on IL-10-producing Breg cells (8) . However, characterization of the phenotypes of Breg cells remains far from complete.
Recently, Tedder and coworkers suggested that IL-10-producing Breg (B10) cells originate from a progenitor population (B10pro). They reported that the activation of CD40 signaling and LPS treatment can induce B10 pro (CD1d 
RESULTS

LPS-stimulated IL-10 production is associated with CD40 expression on B cells
We initially determined whether splenic B cells produce IL-10 upon LPS stimulation. The LPS/TLR4 axis is a well-known trigger for stimulation of intracellular IL-10 expression and secretion from mouse B cells (11 hi or CD40 lo B cells from indicated tissue-derived cells. MFI values are the means ± SEM from three independent experiments: *P ＜ 0.05; **P ＜ 0.01. n.s., not significant. time-dependent manner ( Fig. 1A and 1B) . Accordingly, secretion of IL-10 from Breg cells was strongly elevated in LPS-stimulated B cells (Fig. 1C) . Notably, CD40 expression on B cells was significantly increased by stimulating with LPS for 48 h, but not 5 h (Fig. 1D and 1E ). This result was further confirmed that the expression of CD40 was increased by LPS for 48 h in these cells (Fig. 1F ). Based on these results, we expected that the activation of Breg cells is closely associated with upregulation of CD40 expression.
Next, we investigated whether upregulation of CD40 is associated with IL-10 production in Breg cells. The increase in CD40 expression was apparent by stimulating with LPS for 48 h, and the CD40 expression on IL-10 + B cells was higher than that on IL-10 − B cells (Fig. 1G ). The production of IL-10 by CD40 hi B cells was consistently robust (Fig. 1G) . Next, we phenotypically characterized LPS-induced CD40 hi Breg cells. We could not find any phenotypic differences between CD40 hi and CD40 lo B cells in the expression of IgD, CD11b, CD23, and B220. However, expression of CD1d, CD19, CD21, and CD5 was enhanced by LPS (Fig. 1H) . It was also evident that the production of IL-10 was enhanced in the population of CD40 hi B cells from spleen, mesenteric lymph nodes, inflamed lymph nodes, and blood, but not the peritoneal cavity, compared to CD40 lo B cells (Fig. 1I) . These results suggest that LPS-triggered expansion of the CD40 hi population is closely correlated with the production of IL-10 in Breg cells. the regulatory B cell subsets involved in various autoimmune diseases through IL-10 production (12-15). We therefore sought to determine whether IL-10 production is correlated with phenotypic features of CD40 expression in LPS-stimulated CD5 + Breg cells. As shown in Fig. 2A and 2B , LPS significantly enhanced the IL-10 production in CD5 + B cells, but not CD5 − B cells, in a time-dependent manner. From these results, we hypothesized that LPS-induced CD40 expression is closely correlated with the production of IL-10 in CD5 + B cells. Next, we compared the expression level of CD40 in CD5 + and CD5 − B cells. CD40 expression was increased in both CD5 + and CD5 − B cells by stimulation with LPS ( Fig. 2C and 2D) . Notably, the CD40 expression in CD5 + B cells was much stronger than that in CD5 − B cells after 48 h of LPS stimulation (Fig. 2D) . The analysis of IL-10 expression by flow cytometry and RT-PCR showed that IL-10 was produced in CD40 hi CD5
Expression of IL-10 is dominant in the population
+ B cells, but its expression was minimal in CD40 lo CD5
+ B cells (Fig. 2E-2H ). These results suggest that CD40 expression is closely associated with IL-10 production in Breg cells. (Fig. 3D) . Furthermore, the expansion of CD40 hi expression by LPS was inhibited by AG490, a specific inhibitor of the JAK/STAT3 pathway ( Fig. 3F and 3G ), suggesting that IL-10-induced JAK/STAT3 signaling is critical to the enhancement of CD40 hi CD5 + Breg cells.
Autocrine effect of IL-10 is also critical to the formation of CD40 hi
CD5 + Breg cells in LPS-stimulated mice
To assess the induction of the IL-10-producing CD40 hi population of CD5 + B cells in vivo, we intravenously injected LPS (1 mg/kg) into mice, and then analyzed the production of IL-10-producing splenic CD40 hi CD5 + Breg cells. Similar to the in vitro results, the expression of IL-10 was significantly increased in a time-dependent manner ( Fig. 4A and 4B) . Next, we determined whether the enhancement of CD40 
DISCUSSION
Breg cells have been acknowledged to have anti-inflammatory activity in various immune responses. However, the phenotypic characterization of Breg cells remains incomplete. The goal of our study was to determine the phenotypic features of the induction mechanism of Breg cells. We found that the frequency of Breg cells was increased by LPS treatment. Interestingly, this observation was closely associated with the increased expression of CD40 on B cells. Although the increased expression of CD40 is a typical feature of activated B2 cells (11, 17) , the role and induction mechanism of CD40 in B1a Breg cells are still incompletely understood. We observed that the population of Breg cells was highly enriched in CD40 hi CD5 + B cells, compared to CD40 lo CD5 + B cells ( Fig. 3E and 3F ). These results suggest that the high expression of CD40 on B cells is closely associated with IL-10 production in Breg cells.
We next found unexpectedly that the frequency of CD40 hi CD5 + B cells was increased by various IL-10 inducers including LPS, IL-10, CD40 ligand (CD40L), and BAFF ( Fig. 3A  and 3B ). Although LPS, IL-10, CD40L, and BAFF stimulate different intracellular signaling pathways leading to IL-10 production in Breg cells (17, 21) , the high expression of CD40 on CD5 + B cells was evidenced by the production of IL-10 ( Fig. 3A and 3B) . These results suggest that the formation of CD40 + B cell subsets (Fig. 3C) . However, the formation of CD40 hi CD5
+ Breg cells was blocked by treatment of IL-10 −/− B cells with anti-IL-10 receptor mAb (Fig. 3D and 3E ). These results suggest that the autocrine effect of IL-10 is critical for the formation of the CD40 hi phenotype of Breg cells. Furthermore, the frequency and number of splenic Breg cells were increased by LPS in mice (Fig. 4A and 4B ). The population of CD40 hi CD5
+ B cells was significantly increased in LPS-treated mice, but this was not observed in IL-10 −/− mice (Fig. 4C) . Overall, our results strongly suggest that the expression of CD40 hi and IL-10 in Breg cells is regulated by both autocrine and paracrine mechanisms of IL-10 in vitro and in vivo (Fig. 4D) . It has been well established that the JAK/STAT3 pathway plays a critical role in regulating various IL-10-mediated immune responses (16) . In the present study, the expression of IL-10 and CD40 hi was blocked by inhibiting the JAK/STAT3 pathway with AG490 ( Fig. 3F and 3H ). These observations suggest that the autocrine IL-10 mechanism regulates the JAK/STAT3 pathway-induced formation of IL-10-producing CD40 hi CD5
+ Breg cells. In summary, our data demonstrate that Breg cells were enriched in a population of CD40 hi CD5
+ B cells by treatment with LPS or other stimulants. The signaling pathway is predominantly regulated by autocrine IL-10 ( Fig. 4D ). These findings suggest that the regulation of CD40 expression on Breg cells may provide an additional therapeutic application for various autoimmune and inflammatory diseases.
MATERIALS AND METHODS
Material and Methods are described in the online data supplement, available at http://www.bmbreports.org/.
